S-8 1 zk2431091.htm S-8

As filed with the Securities and Exchange Commission on March 8, 2024
Registration No. 333-_____

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM S-8
 
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
———————————
Entera Bio Ltd.
(Exact name of registrant as specified in its charter)
 
State of Israel
Not Applicable
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification No.)
   
Kiryat Hadassah
Minrav Building – Fifth Floor
Jerusalem, Israel
(Address of Principal Executive Offices)
 
9112002
(Zip Code)

Entera Bio Ltd. 2018 Equity Incentive Plan
(Full title of the plan)

Gerald Lieberman
Director
19 Old Woods Drive
Harrison, New York 10528
(Name, address, including zip code, and telephone number, including area code, of agent for service)

Copies to:

 Drew M. Altman, Esq.
 Sami B. Ghneim, Esq.
Greenberg Traurig, P.A.
333 S.E. 2nd Avenue, Suite 4400
Miami, Florida 33131
(305) 579-0500

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.:
 
Large accelerated filer
☐
  
Accelerated filer
☐
Non-accelerated filer
☒
  
Smaller reporting company
☒
     
Emerging growth company
☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐


STATEMENT OF INCORPORATION BY REFERENCE
 
This Registration Statement is filed by Entera Bio Ltd. (the “Registrant”) for the purpose of registering additional ordinary shares, par value NIS 0.0000769 per share (“Ordinary Shares”), of the Registrant under the Entera Bio Ltd. 2018 Equity Incentive Plan (the “Plan”).
 
The number of Ordinary Shares available for issuance under the Plan is subject to an automatic annual increase on the first day of each calendar year during the term of the Plan equal to the lesser of (i) five percent (5%) of the number of outstanding Ordinary Shares on the last day of the immediately preceding fiscal year and (ii) such smaller number of shares as determined by the Registrant’s Board of Directors (the “Board”), in its discretion (the “Evergreen Provision”). Consequently, pursuant to the Evergreen Provision, the number of Ordinary Shares available for issuance under the Plan increased by an aggregate of 1,773,817 shares on January 1, 2024, which shares are registered under this Registration Statement.
 
Pursuant to Instruction E of Form S-8, the contents of the Registrant’s prior registration statement on Form S-8 registering Ordinary Shares under the Plan (File No. 333-227488) (the “Prior Registration Statement”) is hereby incorporated by reference herein, and the information otherwise required by Form S-8 is omitted, except that the provisions contained in Part II of the Prior Registration Statement are modified as set forth in this Registration Statement.
 
PART II
 
Item 3.
Incorporation of Documents by Reference.
 
The Registrant hereby incorporates by reference into this Registration Statement the following documents previously filed with the Securities and Exchange Commission (the “Commission”):
 

 (a)
The Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023, filed with the Commission on March 8, 2024, pursuant to Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”);
 

 (b)
The Registrant’s Current Report on Form 8-K filed with the Commission on January 3, 2024; and
 

 (c)
The Registrant’s Registration Statement on Form 8-A filed with the Commission on June 25, 2018 (File No. 001-38556), in which there is described the terms, rights and provisions applicable to the Ordinary Shares, including any amendment or report filed for the purpose of updating such description, including the description of the Ordinary Shares filed as Exhibit 4.1 to the Registrant’s Annual Report on Form 10-K filed on March 31, 2023.
 
Additionally, all documents subsequently filed by the Registrant pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act (not including any information furnished under Items 2.02, 7.01 or 9.01 of Form 8-K, which information is not incorporated by reference herein), prior to the filing of a post-effective amendment which indicates that all securities offered hereby have been sold or which deregisters all securities then remaining unsold shall be deemed to be incorporated herein by reference and to be a part of the Registration Statement from the date of filing of such documents. Any statement contained in a document incorporated herein by reference will be deemed to be modified or superseded for purposes of the Registration Statement to the extent that a statement contained herein, or in a subsequently filed document incorporated herein by reference, modifies or supersedes the statement. Any statement modified or superseded will not be deemed, except as modified or superseded, to constitute a part of the Registration Statement.


Item 8.  
Exhibits.

The following are the exhibits required by Item 601 of Regulation S-K:
     
Exhibit No.
  
Description

     

 
 

     

     

     

 
 

 
* Filed herewith.
 

SIGNATURES
 
Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8, and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Jerusalem, State of Israel, on March 8, 2024.
 
 
ENTERA BIO LTD.
 
 
 
By:
Name: 
Title:
/s/ Miranda Toledano  
Miranda Toledano
Chief Executive Officer


POWER OF ATTORNEY
 
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Miranda Toledano and Dana Yaacov-Garbeli, and each of them any of whom may act without joinder of the other, with full power to act as such person’s true and lawful attorneys-in-fact and agent, with full power of substitution and resubstitution, for such person and in such person’s name, place and stead, in any and all capacities, to sign this Registration Statement, and any and all amendments thereto (including post-effective amendments), and to file the same, with exhibits thereto, and all other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agent or his substitute, may lawfully do or cause to be done by virtue hereof.
 
Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the date indicated.

Signature
  
Title
  
Date
         
/s/ Miranda Toledano          
  
Chief Executive Officer and Director
(Principal Executive Officer)
  
March 8, 2024
Miranda Toledano
         
/s/ Dana Yaacov-Garbeli          
  
Chief Financial Officer
(Principal Financial and Accounting Officer)
  
March 8, 2024
Dana Yaacov-Garbeli
 
/s/ Gerald Lieberman          
  
Chairman of the Board
  
March 8, 2024
Gerald Lieberman
 
/s/ Roger J. Garceau          
  
Director
  
March 8, 2024
Roger J. Garceau
 
/s/ Ron Mayron          
  
Director
  
March 8, 2024
Ron Mayron
 
/s/ Yonatan Malca          
  
Director
  
March 8, 2024
Yonatan Malca
 
/s/ Sean Ellis          
  
Director
  
March 8, 2024
Sean Ellis
 
/s/ Haya Taitel          
  
Director
  
March 8, 2024
Haya Taitel
 
/s/ Gerald M. Ostrov          
  
Director
  
March 8, 2024
Gerald M. Ostrov